• slider-dummy-1.jpg
  • image3.jpg
  • image4.jpg

Sandoz is a world leader in generic pharmaceuticals, finding innovative ways to making medicines affordable and accessible to more than 90 percent of the world’s population.

Learn more about our company
Visions and Values

News

Sandoz’ biosimilar rituximab regulatory submission accepted by European Medicines Agency

May 24, 2016

Sandoz, a Novartis division and the global leader in biosimilars, announced today that the European Medicines Agency has accepted their Marketing Authorization Application for a biosimilar to Roche’s EU-licensed MabThera® (rituximab). Rituximab is a monoclonal antibody that is used ...

...

Our people are our greatest resource. We are always looking for new colleagues to share in our commitment to make the world a healthier place.

Learn more about careers at Sandoz

Watch our videos to discover more about the world of Sandoz and the generics market.

Visit our video gallery to watch the latest episode

FAQ

woman.jpg

We have collected the most important and frequently asked questions about our business.

Visit our frequently asked questions page